Lactam inhibitors of hepatitis c virus ns3 protease

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 207/26 (2006.01) A61K 31/4015 (2006.01) A61K 31/45 (2006.01) A61K 31/55 (2006.01) A61K 33/22 (2006.01) A61P 31/14 (2006.01) C07D 211/76 (2006.01) C07D 223/10 (2006.01) C07D 233/12 (2006.01) C07F 5/02 (2006.01) C07K 5/06 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2376961

The present invention relates to lactams of Formula (I) or stereoisomeric forms, stereoisomeric mixtures, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of HCV NS3 protease, and to pharmaceutical compositions and diagnostic kits comprising the same, and methods of using the same for treating viral infection or as an assay standard or reagent.

L'invention concerne des lactames de la formule (I), des formes stéréoisomères, des mélanges stéréoisomères ou leurs formes de sels pharmaceutiquement acceptables, qui sont utiles en tant qu'inhibiteurs de la protéase NS3 du VHC, ainsi que des compositions pharmaceutiques et des trousses de diagnostic les renfermant. Elle concerne enfin leurs procédés d'utilisation pour traiter des infections virales ou comme solution étalon ou réactif pour le dosage.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Lactam inhibitors of hepatitis c virus ns3 protease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Lactam inhibitors of hepatitis c virus ns3 protease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lactam inhibitors of hepatitis c virus ns3 protease will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1631343

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.